AdBlock rilevato
We have detected an active AdBlocker!

Please disable your AdBlocker or add this site to your exceptions.

Our advertising is not intrusive and will not disturb you.
It allows the site to sustain itself, grow, and provide you with new content.

You will not be able to access the content as long as AdBlocker remains active.
After disabling it, this window will close automatically.

Sfondo Header
L'angolo del dottorino
Search the site... Advanced search

Cardiovascular Risk


Arterial hypertension is a major cardiovascular risk factor: the higher the blood pressure values, the higher the risk.
Furthermore, since hypertension is often associated with other diseases and risk factors, a correct risk stratification must consider the number and type of additional risk factors.

Repetition helps: hypertension is defined as:



Based on the severity of blood pressure values, different hypertension grades are distinguished, linked to increasing cardiovascular risk:


Systolic Pressure
(mmHg)
Diastolic Pressure
(mmHg)
Optimal Pressure <120 <80
Normal Pressure 120-129 80-84
Normal-High Pressure 130-139 85-89
Grade 1 Hypertension 140-159 90-99
Grade 2 Hypertension 160-179 100-109
Grade 3 Hypertension ≥180 ≥110

Both normal and normal-high pressures are considered physiological values. Hypertension diagnosis is made for persistently elevated pressure values above 140 mmHg systolic and 90 mmHg diastolic.
Normal-high blood pressure is considered borderline and is also called prehypertension. Subjects with normal-high pressure are not hypertensive but have an increased probability of developing hypertension over time.
For a global evaluation of cardiovascular risk, the presence of other risk factors must also be considered, such as family history, obesity, dyslipidemia, diabetes, atherosclerosis, and other comorbidities with vascular impact.
It should be noted that hypertension often occurs within a more complex condition known as Metabolic Syndrome. Furthermore, its incidence increases with age, and elderly patients often have frailty, precarious homeostasis, multiple diseases, and polypharmacy.

Based on blood pressure levels and the presence or absence of other cardiovascular risk factors, different cardiovascular risk grades are distinguished:


Other Risk Factors

Normal
Pressure
Normal-High
Pressure
Mild
Hypertension
Moderate
Hypertension
Severe
Hypertension
None No additional
risk
No additional
risk
Low Risk Medium Risk High Risk
Up to 2
without diabetes
Low Risk Low Risk Medium Risk Medium Risk Very High
Risk
More than 2
or with diabetes
Medium Risk High Risk High Risk High Risk Very High
Risk
Cardiovascular or
renal disease
Very High
Risk
Very High
Risk
Very High
Risk
Very High
Risk
Very High
Risk
Cardiovascular risk means the increased probability of cardiovascular events within 10 years.
Low Risk
15% or less
Medium Risk
15-20%
High Risk
20-30%
Very High Risk
> 30%
    References
  1. Whelton PK, et al. 2017 ACC/AHA Hypertension Guidelines. J Am Coll Cardiol. 2018;71(19):e127-e248.
  2. Williams B, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021-3104.
  3. Unger T, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. J Hypertens. 2020;38(6):982-1004.
  4. Chrysafinos M, et al. New Insights into Cardiovascular Risk Stratification in Hypertension. Hypertension. 2021;77(4):1203-1214.
  5. James PA, et al. 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults. JAMA. 2014;311(5):507-520.
  6. Carretero OA, Oparil S. Essential hypertension. Part I: Definition and etiology. Circulation. 2000;101(3):329-335.
  7. Fagard RH. Exercise characteristics and the blood pressure response to dynamic physical training. Med Sci Sports Exerc. 2001;33(6 Suppl):S484-S492.
  8. Mancia G, et al. Cardiovascular risk assessment in hypertension. J Hypertens. 2017;35(7):1289-1298.
  9. Piepoli MF, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2016;37(29):2315-2381.
  10. Ferreira JP, et al. Blood pressure targets and cardiovascular outcomes: a review of the evidence. Heart. 2022;108(10):785-792.